Blue-emu Pain Relief Micro-foam
NDC Package 69993-500-35

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Blue-emu Pain Relief Micro-foam is a . Marketed by Kingsway Pharmaceuticals Dba Nfi, Llc, this product is identified by NDC 69993-500 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
69993-500-35
Package Description
99.2 g in 1 CANISTER
Product Code
69993-500
11-Digit Billing Format
69993050035

Clinical Specifications

Proprietary Name
Blue-emu Pain Relief Micro-foam
Dosage Form
-

Regulatory & Marketing

Labeler Name
Kingsway Pharmaceuticals Dba Nfi, Llc
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-05-2021
End Marketing Date
12-31-2025
Listing Expiration
12-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69993-500-35 identifies a specific commercial package of 99.2 g in 1 canister of Blue-emu Pain Relief Micro-foam, labeled by Kingsway Pharmaceuticals Dba Nfi, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Kingsway Pharmaceuticals Dba Nfi, Llc on April 05, 2021. The current certification is valid through December 31, 2025.

How is this Kingsway Pharmaceuticals Dba Nfi, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69993050035. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69993-500-35
11-Digit CMS (5-4-2)
69993-0500-35

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.